Cart summary

You have no items in your shopping cart.

    Recombinant Human TGF-β1

    Recombinant Human TGF-β1

    Catalog Number: orb1921828

    DispatchUsually dispatched within 5-10 working days
    $ 1,770.00
    Catalog Numberorb1921828
    CategoryProteins
    DescriptionTransforming growth factor-β1 (TGF-β1) was the first fully cloned of the TGF-β superfamily members, which are collectively coded by 33 different genes in mammals. TGF-β1 is a homeostatic factor that keeps the immune system in balance and orchestrates the complex tissue repair processes following injury or infection in all organs. Failure of TGF-β1 to regulate normal body repair mechanisms is one commonality of pathological conditions like cancer and fibrosis that both involve dysregulated immunity, inflammation, exacerbated stromal cell activation, and overproduction of extracellular matrix (ECM). As for any other process that involves TGF-β1, there are numerous excellent reviews discussing its role in physiological healing and fibrosis, immunity, and cancer. TGF-β signaling begins when the activated TGF-β ligand docks with type II TGF-β1 receptor (TβRII) subunits on the cell surface, leading to the recruitment of type I TGF-β1 receptor (TβRI) subunits that become phosphorylated and activated by TβRII. In Smad-dependent TGF-β1 signaling, the R-Smads Smad2 and Smad3 are recruited and subsequently phosphorylated by TβRI. The activated Smad2/3 complex assembles with co-Smad4 and translocates to the nucleus, where it associates with co-activators and cell-specific transcription factors to regulate gene expression. Inhibitory Smad7 antagonizes TGF-β signaling by inhibiting R-Smad binding sites on the TβRI. In addition to regulating transcription by phosphorylating Smad2 and Smad3 and facilitating formation of a Smad2/3/4 complex that induces transcription, TGF‑β1 interacts with other signalling pathways. It can activate the mitogen-activated protein kinases (MAPKs), p38, c-Jun N-terminal kinase (JNK) and extracellular signal-related kinases (ERK) in a Smad-independent manner.
    Form/AppearanceLyophilized Powder
    Purity≥95%
    MW12.62 kDa
    Entrez7040
    UniProt IDP01137
    SourceCHO Cell
    Expression SystemEukaryotic cell
    Endotoxins≤10 EU/mg
    StorageUse a manual defrost freezer and avoid repeated freeze - thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -97°C under sterile conditions after reconstitution.
    Alternative namesTransforming Growth Factor Beta 1, Latency-Associa
    Read more...
    NoteFor research use only
    Application notesApplication Notes: For research use only. Minimum Sample Size: 50μg/vial
    Expiration Date6 months from date of receipt.
    Submit a review

    Filter by Rating

      • Star
      • Star
      • Star
      • Star
      • Star
      • 5 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 4 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 3 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 2 stars
      • Star
      • Star
      • Star
      • Star
      • Star
      • 1 stars